196 related articles for article (PubMed ID: 10887041)
1. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
[TBL] [Abstract][Full Text] [Related]
2. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.
Torsello A; Rossoni G; Locatelli V; De Gennaro Colonna V; Bernareggi M; Francolini M; Müller EE; Berti F
Endocrine; 2001 Feb; 14(1):109-12. PubMed ID: 11322492
[TBL] [Abstract][Full Text] [Related]
3. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
[TBL] [Abstract][Full Text] [Related]
4. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
Rossoni G; De Gennaro Colonna V; Bernareggi M; Polvani GL; Müller EE; Berti F
J Cardiovasc Pharmacol; 1998 Aug; 32(2):260-5. PubMed ID: 9700988
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
[TBL] [Abstract][Full Text] [Related]
6. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
[TBL] [Abstract][Full Text] [Related]
7. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Huang J; Li Y; Zhang J; Liu Y; Lu Q
Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model.
Weekers F; Van Herck E; Isgaard J; Van den Berghe G
Endocrinology; 2000 Nov; 141(11):3993-9. PubMed ID: 11089529
[TBL] [Abstract][Full Text] [Related]
9. Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.
Ruigrok TJ; Kirkels JH
Cardioscience; 1990 Sep; 1(3):213-6. PubMed ID: 2102810
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.
Zhang X; Yang JK; Chen C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297647
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
12. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.
Tivesten A; Bollano E; Caidahl K; Kujacic V; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA; Isgaard J
Endocrinology; 2000 Jan; 141(1):60-6. PubMed ID: 10614623
[TBL] [Abstract][Full Text] [Related]
13. Caffeine-induced myocardial injury in calcium-free perfused rat hearts.
Vander Heide RS; Ganote CE
Am J Pathol; 1985 Jan; 118(1):55-65. PubMed ID: 3966537
[TBL] [Abstract][Full Text] [Related]
14. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
Cardiologia; 1997 Nov; 42(11):1165-72. PubMed ID: 9534309
[TBL] [Abstract][Full Text] [Related]
15. Effects of diltiazem on the calcium paradox in isolated rat hearts.
Meno H; Kanaide H; Nakamura M
J Pharmacol Exp Ther; 1984 Jan; 228(1):220-4. PubMed ID: 6694104
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
[TBL] [Abstract][Full Text] [Related]
17. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.
Xu YJ; Saini HK; Zhang M; Elimban V; Dhalla NS
Cardiovasc Res; 2006 Oct; 72(1):163-74. PubMed ID: 16901476
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
Hearse DJ; Ferrari R; Sutherland FJ
J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts.
Ganote CE; Worstell J; Kaltenbach JP
Am J Pathol; 1976 Aug; 84(2):327-50. PubMed ID: 941982
[TBL] [Abstract][Full Text] [Related]
20. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
